Chigenovo Co., Ltd
Chigenovo Co., Ltd
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ZVS101e in Patients With Bietti's Crystalline Dystrophy | Bietti crystalline corneoretinal dystrophy | Not yet recruiting | Not applicable | 2026-08-24 | NCT07653971 | |
| Compassionate Administration of ZVS101e for Extended Treatment | Bietti crystalline corneoretinal dystrophy | Enrolling by invitation | Not applicable | 2026-06-17 | NCT07307469 | |
| Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Recruiting | Phase 1 / Phase 2 | 2026-06-17 | NCT06952842 | |
| Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy | Bietti crystalline corneoretinal dystrophy | Active, not recruiting | Phase 3 | 2026-06-17 | NCT06743646 | |
| Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy | Bietti crystalline corneoretinal dystrophy | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-17 | NCT05832684 | |
| The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4 | Stargardt | Recruiting | Early phase 1 | 2026-04-16 | NCT07241169 |